Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure
Rabies is a deadly viral zoonosis with global disease burden. Following exposure to a rabid animal, post-exposure prophylaxis (PEP) is the standard of care for unvaccinated persons. Despite the large proportion of pediatric cases, limited safety and efficacy data exist for use in pediatric patients....
Saved in:
Main Authors: | Nicholas Hobart-Porter (Author), Michal Stein (Author), Naveh Toh (Author), Novinyo Amega (Author), Huy-Binh Nguyen (Author), James Linakis (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures
by: Ravish S. Haradanhalli, et al.
Published: (2022) -
An epidemiological study of suspected rabies exposures and adherence to rabies post-exposure prophylaxis in Eastern Thailand, 2015.
by: Onphirul Yurachai, et al.
Published: (2020) -
Safety of equine rabies immunoglobulin in grade III bites
by: Chawan V, et al.
Published: (2007) -
IJCM_365A: A prospective study on the safety and clinical efficacy of rabies monoclonal antibodies for post exposure prophylaxis in suspected animal exposures at the anti rabies clinic of KIMS Hospital and Research Centre, Bangalore
by: Poornima M K, et al.
Published: (2024) -
Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial
by: Mark A. Matson, et al.
Published: (2020)